SEOUL – In response to a burgeoning crisis in the supply of essential medical consumables, the South Korean government has announced an emergency initiative to support rare disease patients through telemedicine and direct delivery services. This move, effective as of May 4, aims to ensure that patients receiving home-based care can access critical supplies despite global supply chain disruptions caused by escalating conflicts in the Middle East.

On Monday, the Ministry of Health and Welfare (MOHW) held an emergency meeting at the Seoul National University Hospital Rare Disease Center. The meeting involved representatives from the Korean Organization for Rare Diseases (KORD), medical professionals, and officials from Soldoc, a leading telemedicine platform. During the session, the government confirmed the immediate launch of a specialized direct-delivery system for medical supplies in collaboration with Soldoc.

Navigating a Supply Chain Crisis
Under the Rare Disease Management Act, a rare disease is defined as a condition affecting 20,000 or fewer people in South Korea. Many of these patients rely on daily home treatments requiring syringes, IV sets, suction catheters, and sterile saline. However, recent geopolitical instability in the Middle East has severely impacted the manufacturing and shipping of these plastic-based and clinical-grade materials, leading to frequent stockouts and price hikes.

“The IV sets we used to purchase online are now constantly out of stock,” said a caregiver for a patient with Short Bowel Syndrome. “Every day without these supplies is a day our treatment is compromised.” Another guardian, caring for a child with Cornelia de Lange Syndrome, echoed these fears, noting that the inability to secure syringes and disposable medicine bottles had become a source of constant anxiety.

How the New System Works
To address these concerns, the MOHW and Soldoc have developed a streamlined verification and distribution system. By integrating the platform with the National Health Insurance Service (NHIS) database, the system can instantly verify a user's eligibility as a registered rare disease patient.

For non-reimbursable (out-of-pocket) items, patients can simply order through the app and receive delivery via courier. For items covered under the "National Health Insurance Medical Expenses" scheme, which require a physician's prescription, patients can now utilize telemedicine consultations. The platform will handle the complex billing process to the NHIS, allowing patients to pay only their designated co-payment.

The initial list of prioritized items includes:

Syringes and IV Administration Sets
Suction Tips and Catheters
Sterile Saline and Disinfectant Swabs
The government plans to expand this service to patients with severe chronic diseases and children eligible for medical expense support.

Regulatory Context and Future Outlook
This emergency measure serves as a precursor to the full-scale implementation of the revised Medical Service Act, passed in December 2025. Scheduled to take effect in December 2026, the law officially permits telemedicine for rare disease patients and allows hospital-level institutions—not just local clinics—to provide remote consultations. It also legalizes the delivery of prescription drugs and medical consumables.

Health Minister Jung Eun-kyeong emphasized the government’s commitment: “A rare disease diagnosis should never be a barrier to accessing basic healthcare. We will conduct a thorough investigation into the rising costs of medical consumables and provide additional financial support measures if necessary.”

Industry experts view this as a pivotal moment for South Korea’s digital healthcare sector. By leveraging the infrastructure of private platforms like Soldoc during a national supply crisis, the government is testing the resilience and efficiency of the "Remote Care + Delivery" model before it becomes a permanent fixture of the national healthcare system later this year.

[Copyright (c) Global Economic Times. All Rights Reserved.]